| Global Economic Burden of Norovirus Gastroenteritis SM Bartsch, BA Lopman, S Ozawa, AJ Hall, BY Lee PLOS ONE 11 (4), e0151219, 2016 | 532 | 2016 |
| How do you measure trust in the health system? A systematic review of the literature S Ozawa, P Sripad Social Science & Medicine 91, 10-14, 2013 | 375 | 2013 |
| Return On Investment From Childhood Immunization In Low-And Middle-Income Countries, 2011–20 S Ozawa, S Clark, A Portnoy, S Grewal, L Brenzel, DG Walker Health Affairs 35 (2), 199-207, 2016 | 366 | 2016 |
| Prevalence and Estimated Economic Burden of Substandard and Falsified Medicines in Low-and Middle-Income Countries: A Systematic Review and Meta-analysis S Ozawa, DR Evans, S Bessias, DG Haynie, TT Yemeke, SK Laing, ... JAMA Network Open 1 (4), e181662-e181662, 2018 | 317 | 2018 |
| Cost-effectiveness and economic benefits of vaccines in low-and middle-income countries: a systematic review S Ozawa, A Mirelman, ML Stack, DG Walker, OS Levine Vaccine 31 (1), 96-108, 2012 | 259 | 2012 |
| Modeling The Economic Burden Of Adult Vaccine-Preventable Diseases In The United States S Ozawa, A Portnoy, H Getaneh, S Clark, M Knoll, D Bishai, HK Yang, ... Health Affairs 35 (11), 2124-2132, 2016 | 186 | 2016 |
| Estimated economic impact of vaccinations in 73 low-and middle-income countries, 2001–2020 S Ozawa, S Clark, A Portnoy, S Grewal, ML Stack, A Sinha, A Mirelman, ... Bulletin of the World Health Organization 95 (9), 629, 2017 | 171 | 2017 |
| Public trust and vaccine acceptance-international perspectives S Ozawa, ML Stack Human vaccines & immunotherapeutics 9 (8), 1774-1778, 2013 | 165 | 2013 |
| COVID-19 and risks to the supply and quality of tests, drugs, and vaccines PN Newton, KC Bond, M Adeyeye, M Antignac, A Ashenef, GR Awab, ... The Lancet Global Health 8 (6), e754-e755, 2020 | 158 | 2020 |
| Comparison of trust in public vs private health care providers in rural Cambodia S Ozawa, DG Walker Health Policy and Planning 26 (suppl_1), i20-i29, 2011 | 119 | 2011 |
| Estimated economic benefits during the ‘decade of vaccines’ include treatment savings, gains in labor productivity ML Stack, S Ozawa, DM Bishai, A Mirelman, Y Tam, L Niessen, ... Health Affairs 30 (6), 1021-1028, 2011 | 115 | 2011 |
| Exploring pathways for building trust in vaccination and strengthening health system resilience S Ozawa, L Paina, M Qiu BMC health services research 16 (7), 131-141, 2016 | 112 | 2016 |
| Access to medicines through health systems in low-and middle-income countries S Ozawa, R Shankar, C Leopold, S Orubu Health Policy and Planning 34 (Supplement_3), iii1-iii3, 2019 | 105 | 2019 |
| 10 best resources on… mixed methods research in health systems S Ozawa, K Pongpirul Health policy and planning 29 (3), 323-327, 2014 | 105 | 2014 |
| Decision-making criteria among national policymakers in five countries: a discrete choice experiment eliciting relative preferences for equity and efficiency A Mirelman, E Mentzakis, E Kinter, F Paolucci, R Fordham, S Ozawa, ... Value in health 15 (3), 534-539, 2012 | 91 | 2012 |
| Costs of vaccine programs across 94 low-and middle-income countries A Portnoy, S Ozawa, S Grewal, BA Norman, J Rajgopal, KM Gorham, ... Vaccine 33, A99-A108, 2015 | 89 | 2015 |
| During the ‘decade of vaccines,’the lives of 6.4 million children valued at $231 billion could be saved S Ozawa, ML Stack, DM Bishai, A Mirelman, IK Friberg, L Niessen, ... Health Affairs 30 (6), 1010-1020, 2011 | 82 | 2011 |
| Defining hard-to-reach populations for vaccination S Ozawa, TT Yemeke, DR Evans, SE Pallas, AS Wallace, BY Lee Vaccine 37 (37), 5525-5534, 2019 | 79 | 2019 |
| The economic impact of substandard and falsified antimalarial medications in Nigeria SM Beargie, CR Higgins, DR Evans, SK Laing, D Erim, S Ozawa PloS one 14 (8), e0217910, 2019 | 77 | 2019 |
| Reassessing the value of vaccines T Bärnighausen, S Berkley, ZA Bhutta, DM Bishai, MM Black, DE Bloom, ... The Lancet Global Health 2 (5), e251-e252, 2014 | 69 | 2014 |
